Enfusion (ENFN) has a profit margin of 1.4%, below the Technology sector average of 37.35%.
Get informed when a big investor buys or sells
+ FollowAs of Dec 2024
Trailing 12 months ending Dec 2024
The latest profit margin for ENFN is 1.4% as of December 2024. That compares with 4.45% in the prior-year period — down 68.6% year over year. That is below the Technology sector average of 37.35%. Investors often review this figure alongside Enfusion's historical trend and sector peers before judging valuation or financial health.
Over the past year, ENFN's profit margin moved from 4.45% to 1.4% — a 68.6% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Enfusion's valuation or profitability profile.
Against Technology companies, ENFN currently prints 1.4% for profit margin, while the sector average sits near 37.35%. That is roughly 96.3% below the sector mean. Large gaps often invite a closer look at Enfusion's growth, margins, and balance sheet.
Profit Margin shows how effectively Enfusion converts resources into returns. At 1.4%, ENFN may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with 4.45% in the prior-year period — down 68.6% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting ENFN's profit margin (1.4%), review year-over-year change from 4.45%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.